Johannesburg - Litha Healthcare Group [JSE:LHG], a JSE-listed company with operations in the pharmaceutical, medical devices and biotechnology sectors of the healthcare industry, on Wednesday said it had signed a deal with Cpoint Capital, a Canadian-based firm.
It is headed by Ian Jacobson.
"This agreement represents an exciting and significant step forward for the Litha Group and in particular our Litha pharma division," said group CEO Selwyn Kahanovitz.
Litha Healthcare Group's footprint includes pharmaceutical products, vaccines and medical devices. The tie-up is expected to help grow its pharmaceutical division.
Jacobson will join Litha Healthcare Group's board of directors as a non-executive member.